Healio/OSN top five from Twitter

Recent items have discussed a new Iluvien trial and the history of Bausch + Lomb. Check out five popular items from Healio/OSN’s best-performing tweets below:
Alimera enrolls first patient in Iluvien trial
Alimera Sciences has initiated enrollment for its prospective Iluvien study New Day. Read more.
BLOG: Bausch + Lomb
It feels like it happened just last fall. I can hardly believe that it’s been 17 years since Bausch + Lomb turned 150 years old, but the numbers don’t lie. Read more.
Autologous limbal stem cell transplantation successful in patients with chemical burn
Cultivated

Full Story →